Innovation passport takes Scottish company’s acute stroke treatment to next level
Aurum Biosciences, a clinical stage biopharmaceutical company based in Scotland has been awarded an Innovation Passport for its breakthrough stroke technology A 2015 spinout company of InnoScot Health, NHS Greater Glasgow and Clyde, and the University of Glasgow, Aurum Biosciences develops therapeutics and diagnostics in areas of unmet clinical need. Aurum Biosciences’ lead product ABL-101 … Read more